Thymmune Therapeutics
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
700 Main St, Cambridge, Massachusetts, 0...Website
www.thymmune.comRevenue
$5.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
2
1
1
About Thymmune Therapeutics
Based out of Cambridge, Thymmune Therapeutics, is a biotechnology company with a focus on thymic cell therapies.Explore more
Thymmune Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Thymmune Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Thymmune Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Thymmune Therapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Thymmune Therapeutics
Check out if Thymmune Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Check if Thymmune Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Thymmune Therapeutics launches new products
Funding: Get notified immidiatlly once Thymmune Therapeutics has new funding data
Thymmune Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Thymmune Therapeutics
Find 2 more new buyers
Company Profile Activity
Activity Insights
Thymmune Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Thymmune Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Thymmune Therapeutics.
Thymmune Therapeutics financials insights
Gather financial insights about Thymmune Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Angel/Seed
$7M
Thymmune Therapeutics Tech Stack
A closer look at the technologies used by Thymmune Therapeutics
Thymmune Therapeutics News & Media
Thymmune Therapeutics Receives $37M in Funding from the National Institutes of Health's ...
Thymmune Therapeutics Receives $37M in Funding from the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H)Thymmune Therapeutics Receives $37M in Funding from the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Thymmune Therapeutics Receives $37M in Funding from the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H)
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Thymmune Therapeutics
Sign Up For FreeTo access detailed company insights
Based out of Cambridge, Thymmune Therapeutics, is a biotechnology company with a focus on thymic cell therapies.... Read More
